Y580 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â BCG¹é½Å | BCG vaccine causing adverse effects in therapeutic use |
 |
Y581 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÀåÆ¼Çª½º¿Í ÆÄ¶óƼǪ½º ¹é½Å | Typhoid and paratyphoid vaccine causing adverse effects in therapeutic use |
 |
Y582 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÄÝ·¹¶ó¹é½Å | Cholera vaccine causing adverse effects in therapeutic use |
 |
Y583 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â Æä½ºÆ®¹é½Å | Plague vaccine causing adverse effects in therapeutic use |
 |
Y584 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ÆÄ»ódz¹é½Å | Tetanus vaccine causing adverse effects in therapeutic use |
 |
Y585 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â µðÇÁÅ׸®¾Æ¹é½Å | Diphtheria vaccine causing adverse effects in therapeutic use |
 |
Y586 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹éÀÏÇØ ¼ººÐÀ» °¡Áø ÇÕ¼ºÁ¦ Æ÷ÇÔÇÑ ¹éÀÏÇØ¹é½Å | Pertussis vaccine, including combinations with a pertussis component causing adverse effects in therapeutic use |
 |
Y588 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹éÀÏÇØ ¼ººÐÀ» °¡Áø ÇÕ¼ºÁ¦ Á¦¿ÜÇÑ È¥ÇÕ¼¼±Õ¹é½Å | Mixed bacterial vaccines, except combinations with a pertussis component causing adverse effects in therapeutic use |
 |
Y589 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ¼¼±Õ ¹é½Å | Other and unspecified bacterial vaccines causing adverse effects in therapeutic use |
 |
Y59 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ¹é½Å ¹× »ý¹°ÇÐÀû ¹°Áú | Other and unspecified vaccines and biological substances causing adverse effects in therapeutic use |
 |
Y590 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¹ÙÀÌ·¯½º¹é½Å | Viral vaccines causing adverse effects in therapeutic use |
 |
Y591 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸®ÄÉùé½Å | Rickettsial vaccines causing adverse effects in therapeutic use |
 |
Y592 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¿øÃæ¹é½Å | Protozoal vaccines causing adverse effects in therapeutic use |
 |
Y593 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ¸é¿ª±Û·ÎºÎ¸° | Immunoglobulin causing adverse effects in therapeutic use |
 |
Y598 | Ä¡·á½Ã À¯ÇØÀÛ¿ëÀ» ³ªÅ¸³»´Â ±âŸ ¸í½ÃµÈ ¹é½Å ¹× »ý¹°ÇÐÀû ¹°Áú | Other specified vaccines and biological substances causing adverse effects in therapeutic use |
 |
Y599 | »ó¼¼ºÒ¸íÀÇ ¹é½Å ¶Ç´Â »ý¹°ÇÐÀû ¹°Áú | Vaccine or biological substance, unspecified causing adverse effects in therapeutic use |
 |
Y60 | ¿Ü°úÀû ¹× ³»°úÀû Ä¡·áÁß »ý±ä ºñÀǵµÀû Àý´Ü, õÀÚ, õ°ø ¶Ç´Â ÃâÇ÷ | Unintentional cut, puncture, perforation or hemorrhage during surgical and medical care |
 |
Y600 | ¿Ü°úÀû ¼ö¼úµµÁß »ý±ä ºñÀǵµÀû Àý´Ü, õÀÚ, õ°ø ¶Ç´Â ÃâÇ÷ | Unintentional cut, puncture, perforation or hemorrhage during surgical operation |
 |
Y601 | ÁÖÀÔ ¶Ç´Â ¼öÇ÷µµÁß »ý±ä ºñÀǵµÀû Àý´Ü, õÀÚ, õ°ø ¶Ç´Â ÃâÇ÷ | Unintentional cut, puncture, perforation or hemorrhage during infusion or transfusion |
 |
Y602 | ½ÅÀåÅõ¼® ¶Ç´Â ±âŸ °ü·ùµµÁß »ý±ä ºñÀǵµÀû Àý´Ü, õÀÚ, õ°ø ¶Ç´Â ÃâÇ÷ | Unintentional cut, puncture, perforation or hemorrhage during kidney dialysis or other perfusion |
 |